Ending Parkinson’s Disease

A Prescription for Action

Contributors

By Ray Dorsey, MD

By Todd Sherer, PhD

By Michael S. Okun, MD

By Bastiaan R. Bloem, MD, PhD

Formats and Prices

On Sale
Mar 16, 2021
Page Count
352 pages
Publisher
PublicAffairs
ISBN-13
9781541724501

Price

$19.99

Price

$25.99 CAD

Format:

  1. Trade Paperback $19.99 $25.99 CAD
  2. ebook $12.99 $16.99 CAD
  3. Audiobook Download (Unabridged)

In this “must-read” guide (Lonnie Ali), four leading doctors and advocates offer a bold action plan to prevent, care for, and treat Parkinson’s disease—one of the great health challenges of our time

Brain diseases are now the world’s leading source of disability. The fastest growing of these is Parkinson’s: the number of impacted patients has doubled to more than six million over the last twenty-five years and is projected to double again by 2040. Harmful pesticides that increase the risk of Parkinson’s continue to proliferate, many people remain undiagnosed and untreated, research funding has stagnated, and the most effective treatment is now a half century old.

In Ending Parkinson’s Disease, four top experts provide a plan to help prevent Parkinson’s, improve care and treatment, and end the silence associated with this devastating disease. This is an indispensable guide for patients, families, clinicians, scientists, politicians, and activists.


Ray Dorsey, MD

About the Author

Ray Dorsey is the David M. Levy Professor of Neurology at the University of Rochester, where he directs the Center for Health + Technology. For the past decade, he has pioneered technology to care for individuals with and measure the features of Parkinson disease. His research has been published in the leading neurology, medical, and economic journals and been featured on NPR and in The Wall Street Journal, and The New York Times. Previously, Ray directed the Parkinson disease division at Johns Hopkins Medicine and consulted for McKinsey & Company.

Learn more about this author

Todd Sherer, PhD

About the Author

Todd Sherer, PhD, is the Chief Executive Officer of The Michael J. Fox Foundation for Parkinson’s Research, the largest nonprofit funder of Parkinson’s research. Trained as a neuroscientist, he is responsible for the Foundation’s overall scientific and fundraising direction to speed treatment breakthroughs and a cure for Parkinson’s disease. After a postdoctoral fellowship at Emory University investigating the role of environmental factors in Parkinson’s, Todd joined the Foundation’s staff in 2004 and was named Chief Executive Officer in 2011.

Learn more about this author